HomeCompareBPCP vs PFE

BPCP vs PFE: Dividend Comparison 2026

BPCP yields 29100.00% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BPCP wins by $2.181048452443935e+21M in total portfolio value
10 years
BPCP
BPCP
● Live price
29100.00%
Share price
$0.03
Annual div
$8.73
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2.181048452443935e+21M
Annual income
$2,166,403,628,259,168,600,000,000,000.00
Full BPCP calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — BPCP vs PFE

📍 BPCP pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBPCPPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BPCP + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BPCP pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BPCP
Annual income on $10K today (after 15% tax)
$2,473,500.00/yr
After 10yr DRIP, annual income (after tax)
$1,841,443,084,020,293,100,000,000,000.00/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, BPCP beats the other by $1,841,443,084,020,293,100,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BPCP + PFE for your $10,000?

BPCP: 50%PFE: 50%
100% PFE50/50100% BPCP
Portfolio after 10yr
$1.0905242262219675e+21M
Annual income
$1,083,201,814,129,584,300,000,000,000.00/yr
Blended yield
99.33%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

BPCP
No analyst data
Altman Z
-0.2
Piotroski
1/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BPCP buys
0
PFE buys
0
No recent congressional trades found for BPCP or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBPCPPFE
Forward yield29100.00%6.13%
Annual dividend / share$8.73$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%13.2%
Portfolio after 10y$2.181048452443935e+21M$49.6K
Annual income after 10y$2,166,403,628,259,168,600,000,000,000.00$26,258.71
Total dividends collected$2.18008472748864e+21M$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: BPCP vs PFE ($10,000, DRIP)

YearBPCP PortfolioBPCP Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$2,920,700$2,910,000.00$9,153$693.39+$2.91MBPCP
2$797,446,364$794,321,214.95$8,593$849.25+$797.44MBPCP
3$203,540,744,167$202,687,476,557.26$8,336$1,066.78+$203540.74MBPCP
4$48,567,402,897,557$48,349,614,301,298.39$8,437$1,384.80+$48567402.89MBPCP
5$10,834,052,308,549,964$10,782,085,187,449,578.00$9,013$1,875.40+$10834052308.54MBPCP
6$2,259,430,539,035,731,700$2,247,838,103,065,582,800.00$10,306$2,680.72+$2259430539035.72MBPCP
7$440,533,795,929,311,300,000$438,116,205,252,543,000,000.00$12,820$4,101.38+$440533795929311.25MBPCP
8$80,304,982,704,211,880,000,000$79,833,611,542,567,520,000,000.00$17,673$6,826.70+$80304982704211872.00MBPCP
9$13,686,751,574,548,174,000,000,000$13,600,825,243,054,670,000,000,000.00$27,543$12,591.86+$13686751574548174848.00MBPCP
10$2,181,048,452,443,935,200,000,000,000$2,166,403,628,259,168,600,000,000,000.00$49,560$26,258.71+$2.181048452443935e+21MBPCP

BPCP vs PFE: Complete Analysis 2026

BPCPStock

Bishop Capital Corporation, through its subsidiaries, engages in the development and sale of real estate properties in the United States. The company owns and operates a 328 unit apartment complex located in Colorado Springs, Colorado. It also owns approximately 2 acres of developed and 16 acres of undeveloped land in Colorado. The company is developing a 16 acre parcel called The Crossing at Palmer Park and 11 acre parcel called Creekside Center at Galley. In addition, it has a royalty interest in a natural gas property located in Wyoming. Bishop Capital, formerly known as Bishop Cable Communications Corporation, was incorporated in 1983 and changed its name to Bishop Capital Corporation in 1995. The company is based in Riverton, Wyoming.

Full BPCP Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this BPCP vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BPCP vs SCHDBPCP vs JEPIBPCP vs OBPCP vs KOBPCP vs MAINBPCP vs JNJBPCP vs MRKBPCP vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.